Sector
PharmaceuticalsOpen
₹7Prev. Close
₹6.99Turnover(Lac.)
₹0Day's High
₹7Day's Low
₹752 Week's High
₹052 Week's Low
₹0Book Value
₹-16.91Face Value
₹10Mkt Cap (₹ Cr.)
7.7P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Equity Capital | 10.85 | 10.85 | 10.85 | 10.85 |
Preference Capital | 19.18 | 19.18 | 19.18 | 0 |
Reserves | -29.43 | -28.44 | -28.21 | -27.89 |
Net Worth | 0.6 | 1.59 | 1.82 | -17.04 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.02 | 0 | -0.11 | -0.16 |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Profit before tax | -0.19 | -0.29 | -0.63 | -0.15 |
Depreciation | -0.14 | -0.14 | -0.14 | -0.15 |
Tax paid | -0.03 | -0.02 | 0 | 0 |
Working capital | -0.08 | -0.2 | 0.03 | 0.12 |
Other operating items |
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | -47.03 | -65.76 | 143.71 | -30.43 |
EBIT growth | -34.18 | -52.18 | 306.85 | -76.67 |
Net profit growth | -27.39 | -49.11 | 313.66 | -76.7 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,809.65 | 156.66 | 4,31,892.29 | 863.29 | 0.75 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,096 | 90.43 | 1,66,128.91 | 518 | 0.48 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,498.9 | 28.64 | 1,21,230.71 | 1,178.16 | 0.87 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,362.95 | 69.29 | 1,13,360.59 | 460 | 0.84 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,619.1 | 51.91 | 1,04,061.97 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Shaibal Kumar Chakraborty
Director
Kingshuk Sengupta
Independent Director
Pradip Kumar Chakravorty
Independent Director
Badal Modak
Director
Sanghamitra Sen
Additional Director
Monika Bhattacharjee
Additional Director
Dipak Chandra Ray
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Senbo Industries Ltd
Summary
Senbo Industries Ltd., incorporated in 1994 as private limited company it was converted into public limited company in 1996, when it went public. On it maiden public issue in this year the company has issued 11000000 equity shares of Rs.10/- each. The company is into manufacture of Intravenous Fluids (I V Fluids) with an installed capacity of 18000000 nos. of bottles(as on March 31, 2001).
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
